Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer

G Kallifatidis, JJ Hoy, BL Lokeshwar - Seminars in cancer biology, 2016 - Elsevier
Prostate cancer (PCa), a hormonally-driven cancer, ranks first in incidence and second in
cancer related mortality in men in most Western industrialized countries. Androgen and …

CD9, a tetraspanin target for cancer therapy?

A Lorico, M Lorico-Rappa… - Experimental …, 2021 - journals.sagepub.com
In the present minireview, we intend to provide a brief history of the field of CD9 involvement
in oncogenesis and in the metastatic process of cancer, considering its potential value as a …

Genome-wide analysis of somatic noncoding mutation patterns in cancer

F Dietlein, AB Wang, C Fagre, A Tang, NJM Besselink… - Science, 2022 - science.org
We established a genome-wide compendium of somatic mutation events in 3949 whole
cancer genomes representing 19 tumor types. Protein-coding events captured well …

Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion

JS Brzozowski, DR Bond, H Jankowski, BJ Goldie… - Scientific reports, 2018 - nature.com
To facilitate intercellular communication, cells release nano-sized, extracellular vesicles
(EVs) to transfer biological cargo to both local and distant sites. EVs are enriched in …

Exposure to an environmentally relevant phthalate mixture during prostate development induces microRNA upregulation and transcriptome modulation in rats

WR Scarano, A Bedrat, LG Alonso-Costa… - Toxicological …, 2019 - academic.oup.com
Environmental exposure to phthalates during intrauterine development might increase
susceptibility to neoplasms in reproductive organs such as the prostate. Although studies …

Prediction of tumor location in prostate cancer tissue using a machine learning system on gene expression data

O Hamzeh, A Alkhateeb, J Zheng, S Kandalam… - BMC …, 2020 - Springer
Background Finding the tumor location in the prostate is an essential pathological step for
prostate cancer diagnosis and treatment. The location of the tumor–the laterality–can be …

Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer

C Soekmadji, JD Riches, PJ Russell, JE Ruelcke… - …, 2016 - pmc.ncbi.nlm.nih.gov
Proliferation and maintenance of both normal and prostate cancer (PCa) cells is highly
regulated by steroid hormones, particularly androgens, and the extracellular environment …

Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms

NC Emami, L Kachuri, TJ Meyers, R Das… - Nature …, 2019 - nature.com
Here we train cis-regulatory models of prostate tissue gene expression and impute
expression transcriptome-wide for 233,955 European ancestry men (14,616 prostate cancer …

EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy

Y Ding, J Chen, S Li, JD Wren, AK Bajpai, J Wang… - Oncogene, 2023 - nature.com
Experimental studies on immunoglobulin superfamily (IgSF) member EWI2 reveal that it
suppresses a variety of solid malignant tumors including brain, lung, skin, and prostate …

The SMARCD family of SWI/SNF accessory proteins is involved in the transcriptional regulation of androgen receptor-driven genes and plays a role in various …

IE Ertl, R Brettner, H Kronabitter, T Mohr, S Derdak… - Cells, 2022 - mdpi.com
Previous studies have demonstrated an involvement of chromatin-remodelling SWI/SNF
complexes in the development of prostate cancer, suggesting both tumor suppressor and …